Page 23 - Air Force Material Command News Today : Breaking News, Live Updates & Top Stories | Vimarsana

CytoSorb® Registered and Commercially Available in Singapore CytoSorbents announces immediate commercial availability of CytoSorb in Singapore through distributor Humedical News provided by Share this article MONMOUTH JUNCTION, N.J., May 25, 2021 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a critical care leader commercializing its CytoSorb® blood purification technology to treat deadly conditions in the intensive care unit (ICU) and cardiac surgery, announces that the Singapore Health Sciences Authority (HSA) has now approved registration of CytoSorb® for all equivalent Eu...

WRIGHT-PATTERSON AIR FORCE BASE, Ohio (AFRL) – A senior technical advisor with the Air Force Research Laboratory’s Aerospace Systems Directorate inspired her daughter to embark on a military career full of adventure and multicultural experiences.Lisa,

    Col. Louis Ruscetta, as an Air Force brat, has spent much of his life at flightlines around the world.  Today, he serves as Senior Materiel Leader for the B-52 program office and leads a team that is working to ensure the B-52 is available when the nation calls.    “There's such a special culture in the BUFF [Big Ugly Fat Fellow] that you're part of something that's unique and historic,” Ruscetta said during an episode of AFLCMC’s Leadership Log podcast.  “There's just this love of the platform. And it's not really inspired by a leader because we come and go.  It's really i...

/PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a critical care leader commercializing its CytoSorb® blood purification technology to treat deadly...

Share this article Share this article MONMOUTH JUNCTION, N.J., May 11, 2021 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a critical care leader commercializing its CytoSorb® and other blood purification technologies to treat deadly conditions in critically-ill and cardiac surgery patients around the world, announced the U.S Army Medical Research and Development Command has awarded CytoSorbents a Defense Health Agency (DHA) Sequential Phase II Small Business Innovation Research (SBIR) contract, valued at $1,499,987 over 28 months, to advance development of the K +ontrol™ platf...